N/A

Average User
Rating
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis

USD 0.23

0.00 (0.00)%

USD 0.01B

0.81M

USD 3.00(+1,204.35%)

N/A

Icon

AGRX

Agile Thrpe (USD)
COMMON STOCK | NSD
USD 0.23
0.00 0

N/A

Average User
Rating
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis

USD 0.01B

N/A

USD 0.23

Agile Thrpe Stock Forecast

Show ratings and price targets of :
USD 3.00
(+1,204.35%)

Based on the Agile Thrpe stock forecasts from 2 analysts, the average analyst target price for Agile Thrpe is USD 3.00 over the next 12 months. Agile Thrpe’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Agile Thrpe is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Agile Thrpe’s stock price was USD 0.23. Agile Thrpe’s stock price has changed by +9.52% over the past week, -4.56% over the past month and -97.83% over the last year.

No recent analyst target price found for Agile Thrpe
No recent average analyst rating found for Agile Thrpe

Company Overview

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive p...Read More

500 College Road East, Princeton, NJ, United States, 08540

N/A

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Agile Thrpe (Sector: Drug Manufacturers-Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
PPD
PPD Inc 0.00 (0.00%) USD16.61B 47.04 21.58

ETFs Containing AGRX

Symbol Name Weight Mer Price(Change) Market Cap
no data

Frequently Asked Questions About AGRX Stock

Based on ratings from 2 analysts Agile Thrpe's stock is Buy . Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and 1 hold ratings.

Unfortunately we do not have enough data on AGRX's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for AGRX is USD 3.00 over the next 12 months. The maximum analyst target price is USD 3 while the minimum anlayst target price is USD 3.

Unfortunately we do not have enough data on AGRX's stock to indicate if its overvalued.

The last closing price of AGRX's stock was USD 0.23.

The most recent market capitalization for AGRX is USD 0.01B.

Based on targets from 2 analysts, the average taret price for AGRX is projected at USD 3.00 over the next 12 months. This means that AGRX's stock price may go up by +1,204.35% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...